Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing ManagementThe Neurologist 8:227-236, Frohman,E.,et al, 2002
Tasmar (tolcapone) Labeling Revisions of Package InsertRoche Laboratories, , 1998